Simplify mutation interpretation
Efficiently assess mutation significance to streamline lab workflows for greater productivity.
Overview
Empowering next-generation sequencing labs with an efficient clinical reporting solution
Interpret the research and clinical significance of mutations accurately and efficiently with navify Mutation Profiler, a CE-IVD* clinical NGS reporting solution. Empower your lab to deliver concise, professional reports that inform oncologists on potential personalised treatment strategies, supporting more personalised healthcare.
Enable personalised treatment insights
Deliver concise reports that help oncologists identify personalised treatment strategies.
Automate NGS reporting workflows
Reduce curation time by up to 75% and support expanded panel and mutation analysis with automation.1
navify® Mutation Profiler
Simplifying NGS research and clinical interpretation.
Making NGS research and clinical interpretation simpler
navify Mutation Profiler enhances NGS workflows with automated reporting, pre-configured variant summaries and therapy insights. Its intuitive design and seamless integrations support labs in delivering consistent, personalised insights for precision oncology.
Automated reporting and streamlined curation
navify Mutation Profiler has been shown to reduce the time needed to draft a curation report by 75%.¹ It increases reproducibility while automating report generation workflows. The solution supports broader gene panels, cancers and mutations with pre-configured clinical and variant summaries, simplifying interpretation and saving time. Centralised annotations enable lab teams to efficiently access and interpret data for faster, more accurate insights.
Comprehensive mutation insights
Gain clear insights into mutations and potential treatment options with simpler, concise reports. navify Mutation Profiler provides research and clinical significance details for thousands of common variants, classified per Association for Molecular Pathology guidelines, plus public annotations for millions more. Labs can access links to actionable therapies supported by regulatory agencies, clinical studies and medical guidelines for informed decision-making.
Intuitive and user-friendly
Developed with lab clinician input, this solution offers a clean, intuitive interface, enhancing the lab experience and enabling clear communication of personalised treatment options in concise reports for researchers and oncologists. It includes comprehensive lab and variant analytics with optional classification-sharing and seamlessly integrates with laboratory information systems and electronic medical records via APIs, streamlining workflows and improving efficiency.
Frequently asked questions about navify Mutation Profiler
If you don’t find answers to your questions here, we’re happy to provide more information and discuss your needs in detail.
What is navify Mutation Profiler, and how does it support precision medicine and research?
navify Mutation Profiler is a NGS reporting solution designed to streamline the interpretation of genetic mutations for both clinical and research purposes. By delivering up-to-date, clinically relevant insights, it enables labs to generate concise, actionable reports, enabling clinicians in delivering personalised treatment options and helping researchers uncover insights that drive future advancements.
How does navify Mutation Profiler improve reporting efficiency in labs?
navify Mutation Profiler significantly reduces the time needed for mutation curation and report generation by automating processes and organising data in a centralised location. This allows labs to support more gene panels and analyse a wider range of mutations more effectively.
What kind of information does navify Mutation Profiler provide in its reports?
Reports generated by navify Mutation Profiler offer a clear presentation of mutation significance, potential treatment options and clinical relevance based on Association for Molecular Pathology guidelines. They also include links to therapy options supported by drug agencies, clinical studies and medical guidelines.
Can navify Mutation Profiler integrate with existing lab systems?
Yes, navify Mutation Profiler integrates seamlessly with laboratory information systems (LIS) and electronic medical records (EMR) through APIs, supporting lab workflows and enabling easy data sharing across platforms.
How does navify Mutation Profiler enhance the user experience for lab clinicians?
Developed with clinician input, navify Mutation Profiler features a clean, intuitive interface that simplifies navigation and improves workflow efficiency. This design supports the quick interpretation of mutation data and enables labs to generate clear, professional reports for oncologists and researchers.
Roche
At Roche Diagnostics, we understand the need to go beyond our products and see the bigger picture, creating a world where product and services come together. Roche Service Solutions refers to our service offering and encompasses our full service portfolio. Our total solution package means we can provide you with the personalised mix of products and services you need. Our digital services enable you to quickly connect with us and help make your life more manageable.
Visit website- Yaung SJ, Pek A. From information overload to actionable insights: digital solutions for interpreting cancer variants from genomic testing. JMP. 2021;2(4):312–318. [DOI: 10.3390/jmp2040027].
- Not every digital product is available in all markets. The use of any third-party app is subject to a separate licence agreement with the respective third-party app developer. Roche gives no warranties (express or implied) with regard to any third-party app. Third-party apps might not be available in your country. This website and its content may be accessible worldwide; Roche assumes no liability with regard to the access to the information, which may not be compatible with legislations or regulations in force in your country.
- *navify Mutation Profiler is CE-IVD. In the US, navify Mutation Profiler is Research Use Only (RUO). Not for use in diagnostic procedures or decisions.
- MC--15707